BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 19232335)

  • 1. Soluble CD40 ligand and soluble P-selectin levels in Gilbert's syndrome: a link to protection against atherosclerosis?
    Tapan S; Dogru T; Tasci I; Ercin CN; Ozgurtas T; Erbil MK
    Clin Biochem; 2009 Jun; 42(9):791-5. PubMed ID: 19232335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The levels of circulating markers of atherosclerosis and inflammation in subjects with different degrees of body mass index: Soluble CD40 ligand and high-sensitivity C-reactive protein.
    Guldiken S; Demir M; Arikan E; Turgut B; Azcan S; Gerenli M; Tugrul A
    Thromb Res; 2007; 119(1):79-84. PubMed ID: 16476470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble P-selectin and CD40L levels in subjects with prediabetes, diabetes mellitus, and metabolic syndrome--the Chennai Urban Rural Epidemiology Study.
    Gokulakrishnan K; Deepa R; Mohan V; Gross MD
    Metabolism; 2006 Feb; 55(2):237-42. PubMed ID: 16423632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of low-grade inflammation and platelet activation in patients with hypertension with microalbuminuria.
    Ferroni P; Guagnano MT; Falco A; Paoletti V; Manigrasso MR; Michetti N; Santilli F; Guadagni F; Basili S; Davì G
    Clin Sci (Lond); 2008 Mar; 114(6):449-55. PubMed ID: 17988217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diverse associations of microalbuminuria with C-reactive protein, interleukin-18 and soluble CD 40 ligand in male essential hypertensive subjects.
    Tsioufis C; Dimitriadis K; Taxiarchou E; Vasiliadou C; Chartzoulakis G; Tousoulis D; Manolis A; Stefanadis C; Kallikazaros I
    Am J Hypertens; 2006 May; 19(5):462-6. PubMed ID: 16647614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [sCD40L, sP-selectin and sICAM-1 plasma levels in nasopharyngeal carcinoma].
    Li L; Li P; Yang YQ; Zhang H; Ai P; Wang F; Jiang Y; Zou LQ; Yan X; Luo F
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):513-6. PubMed ID: 19627017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.
    Tan KT; Tayebjee MH; Lim HS; Lip GY
    Diabet Med; 2005 Dec; 22(12):1657-62. PubMed ID: 16401308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention.
    Lim HS; Blann AD; Lip GY
    Circulation; 2004 Jun; 109(21):2524-8. PubMed ID: 15136493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased plasma levels of soluble CD40 ligand correlate with platelet activation markers and underline the need for standardized pre-analytical conditions.
    Riondino S; Martini F; La Farina F; Spila A; Guadagni F; Ferroni P
    Clin Biochem; 2010 May; 43(7-8):666-70. PubMed ID: 20060822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin diminishes platelet aggregation and sCD40L release. Potential role in the metabolic syndrome.
    Restituto P; Colina I; Varo JJ; Varo N
    Am J Physiol Endocrinol Metab; 2010 May; 298(5):E1072-7. PubMed ID: 20197504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein but not soluble CD40 ligand and homocysteine is associated to common atherosclerotic risk factors in a cohort of coronary artery disease patients.
    Vivona N; Bivona G; Noto D; Sasso BL; Cefalù AB; Chiarello G; Falletta A; Ciaccio M; Averna MR
    Clin Biochem; 2009 Nov; 42(16-17):1713-8. PubMed ID: 19732763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating CD40 ligand is elevated only in patients with more advanced symptomatic peripheral arterial diseases.
    Lee WJ; Sheu WH; Chen YT; Liu TJ; Liang KW; Ting CT; Lee WL
    Thromb Res; 2006; 118(5):619-26. PubMed ID: 16356539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble CD40 ligand, soluble P-selectin and von Willebrand factor levels in subjects with prediabetes: the impact of metabolic syndrome.
    Genc H; Dogru T; Tapan S; Tasci I; Bozoglu E; Gok M; Aslan F; Celebi G; Erdem G; Avcu F; Ural AU; Sonmez A
    Clin Biochem; 2012 Jan; 45(1-2):92-5. PubMed ID: 22100896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble p-selectin, D-dimer, and high-sensitivity C-reactive protein after acute deep vein thrombosis of the lower limb.
    Gremmel T; Ay C; Seidinger D; Pabinger I; Panzer S; Koppensteiner R
    J Vasc Surg; 2011 Dec; 54(6 Suppl):48S-55S. PubMed ID: 21890302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma, serum, and platelet expression of CD40 ligand in adults with cardiovascular disease.
    Mason PJ; Chakrabarti S; Albers AA; Rex S; Vitseva O; Varghese S; Freedman JE
    Am J Cardiol; 2005 Nov; 96(10):1365-9. PubMed ID: 16275179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-conventional markers of atherosclerosis before and after gastric banding surgery.
    Hanusch-Enserer U; Zorn G; Wojta J; Kopp CW; Prager R; Koenig W; Schillinger M; Roden M; Huber K
    Eur Heart J; 2009 Jun; 30(12):1516-24. PubMed ID: 19380349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum brain-derived neurotrophic factor and platelet activation evaluated by soluble P-selectin and soluble CD-40-ligand in patients with acute myocardial infarction.
    Lorgis L; Amoureux S; de Maistre E; Sicard P; Bejot Y; Zeller M; Vergely C; Sequeira-Le Grand A; Lagrost AC; Berchoud J; Cottin Y; Rochette L
    Fundam Clin Pharmacol; 2010 Aug; 24(4):525-30. PubMed ID: 19909348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of soluble CD40 ligand are elevated in inflammatory bowel diseases.
    Ludwiczek O; Kaser A; Tilg H
    Int J Colorectal Dis; 2003 Mar; 18(2):142-7. PubMed ID: 12548417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes of soluble CD40 ligand in patients with hyperlipidemia of blood stasis syndrome and its clinical significance].
    Jin L; He LR; Fu DY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Mar; 31(3):315-8. PubMed ID: 21485068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes and relations of soluble plasma CD40L and matrix metalloproteinase-9 levels in patients with coronary heart disease].
    Li J; Zhao SP; Peng DQ; Zhou HN
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 29(5):517-20. PubMed ID: 16137036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.